Kaleido Biosciences (KLDO) Short Interest Ratio & Short Volume $0.0001 0.00 (0.00%) As of 08/4/2025 03:03 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Kaleido Biosciences Short Interest DataKaleido Biosciences (KLDO) has a short interest of 67,200 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 672.0, indicating that it would take 672.0 days of the average trading volume of 12,091 shares to cover all short positions.Current Short Interest67,200 sharesPrevious Short Interest67,200 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio672.0 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares42,623,000 sharesPercentage of Shares Shorted0.16%Today's Trading Volume1,522 sharesAverage Trading Volume12,091 sharesToday's Volume Vs. Average13% Short Selling Kaleido Biosciences? Sign up to receive the latest short interest report for Kaleido Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKLDO Short Interest Over TimeKLDO Days to Cover Over TimeKLDO Percentage of Float Shorted Over Time Kaleido Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202567,200 shares $0.00 No ChangeN/A672 $0.00 6/30/202567,200 shares $6.72 No Change0.2%3 $0.00 6/15/202567,200 shares $6.72 No Change0.2%96 $0.00 5/31/202567,200 shares $6.72 No Change0.2%30.5 $0.00 5/15/202567,200 shares $13.44 +2.9%N/A168 $0.00 4/30/202565,300 shares $6.53 No ChangeN/A93.3 $0.00 4/15/202565,300 shares $6.53 No ChangeN/A15.2 $0.00 3/14/202565,300 shares $6.53 No ChangeN/A93.3 $0.00 2/14/202565,300 shares $0.00 No ChangeN/A0 $0.00 1/31/202565,300 shares $0.00 No ChangeN/A653 $0.00 Get the Latest News and Ratings for KLDO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kaleido Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202565,300 shares $0.00 No ChangeN/A326.5 $0.00 4/15/20221,400,000 shares $406 thousand -40.2%7.3%0.3 $0.29 3/31/20222,340,000 shares $3.86 million +0.4%12.2%3.9 $1.65 3/15/20222,330,000 shares $3.24 million +7.9%12.2%19.8 $1.39 2/28/20222,160,000 shares $3.22 million +3.4%11.3%16.5 $1.49 2/15/20222,090,000 shares $3.39 million +7.7%10.9%15.3 $1.62 1/31/20221,940,000 shares $3.41 million -5.4%10.1%13.4 $1.76 1/15/20222,050,000 shares $4.53 million -4.2%10.7%14.6 $2.21 12/31/20212,140,000 shares $5.11 million -3.2%11.2%15.3 $2.39 12/15/20212,210,000 shares $6.81 million -5.2%11.5%15.2 $3.08 11/30/20212,330,000 shares $8.36 million +5.9%12.2%16.9 $3.59 11/15/20212,200,000 shares $10.34 million +2.8%11.5%17 $4.70 10/29/20212,140,000 shares $9.20 million -4.0%11.2%17 $4.30 10/15/20212,230,000 shares $11.02 million -15.2%11.6%17.4 $4.94 9/30/20212,630,000 shares $14.36 million -0.8%13.7%18.4 $5.46 9/15/20212,650,000 shares $14.26 million +2.7%13.8%10.9 $5.38 8/31/20212,580,000 shares $15.84 million -21.1%13.5%10.3 $6.14 8/13/20213,270,000 shares $20.08 million -7.9%17.1%12.7 $6.14 7/30/20213,550,000 shares $19.28 million +2.6%18.6%13.4 $5.43 7/15/20213,460,000 shares $23.77 million +1.2%18.1%12.4 $6.87 6/30/20213,420,000 shares $25.44 million +0.9%17.9%10.1 $7.44 6/15/20213,390,000 shares $22.27 million +0.3%17.8%9.6 $6.57 5/28/20213,380,000 shares $24.27 million +1.8%17.7%12.6 $7.18 5/14/20213,320,000 shares $19.32 million +2.2%17.4%11.6 $5.82 4/30/20213,250,000 shares $26.16 million +7.3%17.0%9.9 $8.05 4/15/20213,030,000 shares $20.82 million +7.8%15.9%8 $6.87 3/31/20212,810,000 shares $20.40 million +11.5%15.3%9.1 $7.26 3/15/20212,520,000 shares $25.28 million -3.1%13.7%9.1 $10.03 2/26/20212,600,000 shares $24.93 million -5.8%17.8%10 $9.59 2/12/20212,760,000 shares $33.62 million -15.9%19.4%11.7 $12.18Trump set to Boost Social Security Checks by 400%? (Ad)If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...Click here to see the details because the stakes couldn't be any higher. 1/29/20213,280,000 shares $55.17 million -2.4%22.7%16.1 $16.82 1/15/20213,360,000 shares $43.95 million +1.5%26.6%25.5 $13.08 12/31/20203,310,000 shares $31.78 million +12.2%26.2%24.1 $9.60 12/15/20202,950,000 shares $28.85 million -15.2%23.3%11.1 $9.78 11/30/20203,480,000 shares $26.52 million +3.0%27.5%13.3 $7.62 11/15/20203,380,000 shares $24.17 million +4.6%27.4%12.7 $7.15 10/30/20203,230,000 shares $20.32 million +6.3%26.2%11.9 $6.29 10/15/20203,040,000 shares $29.40 million +10.6%24.9%11 $9.67 9/30/20202,750,000 shares $30.44 million +15.1%22.5%10.1 $11.07 9/15/20202,390,000 shares $14.05 million +3.9%19.6%11.1 $5.88 8/31/20202,300,000 shares $14.47 million -1.3%18.9%15.4 $6.29 8/14/20202,330,000 shares $18.41 million +0.9%19.4%12.7 $7.90 KLDO Short Interest - Frequently Asked Questions What is Kaleido Biosciences' current short interest? Short interest is the volume of Kaleido Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 67,200 shares of KLDO short. Learn More on Kaleido Biosciences' current short interest. What is a good short interest ratio for Kaleido Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KLDO shares currently have a short interest ratio of 672.0. Learn More on Kaleido Biosciences's short interest ratio. How does Kaleido Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "computer software" compare to Kaleido Biosciences: X3 Holdings Co., Ltd. (0.24%), Lottery.com Inc. (5.70%), LIZHI INC. Sponsored ADR (1.77%), MMTec, Inc. (0.41%), Moatable, Inc. (0.03%), Streamline Health Solutions, Inc. (0.65%), XIAO-I Corporation Unsponsored ADR (2.53%), Healthcare Triangle, Inc. (0.79%), Hitek Global Inc. (0.06%), CXApp Inc. (4.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Kaleido Biosciences stock? Short selling KLDO is an investing strategy that aims to generate trading profit from Kaleido Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kaleido Biosciences? A short squeeze for Kaleido Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KLDO, which in turn drives the price of the stock up even further. How often is Kaleido Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KLDO, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies X3 Short Interest Data Lottery.com Short Interest Data LIZHI Short Interest Data MMTec Short Interest Data Moatable Short Interest Data Streamline Health Solutions Short Interest Data XIAO-I Short Interest Data Healthcare Triangle Short Interest Data Hitek Global Short Interest Data CXApp Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KLDO) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.